NCT06352216 Prevalence of Synovitis in Patients With Haemophilia A
| NCT ID | NCT06352216 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bonn |
| Condition | Haemophilia A |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-04-15 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the prevalence of synovitis in adult patients with haemophilia A.
Eligibility Criteria
Inclusion Criteria: * Participants (≥ 18 years old) suffering from moderate or severe haemophilia A, also with inhibitor or joint replacement * Complete documentation of hemophilia severity, treatment history (past 12 months), and bleeding events (past 12 months), inhibitor status (at time of enrollment and in past medical history) * Submitted written consent to participate in the study Exclusion Criteria: * Patients suffering from other bleeding disorders conflicting with the research question * Patients in clinical studies with investigational drugs
Contact & Investigator
Andreas C Strauss, PD Dr. med.
PRINCIPAL INVESTIGATOR
University Hospital, Bonn
Frequently Asked Questions
Who can join the NCT06352216 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Haemophilia A. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06352216 currently recruiting?
Yes, NCT06352216 is actively recruiting participants. Contact the research team at andreas.strauss@ukbonn.de for enrollment information.
Where is the NCT06352216 trial being conducted?
This trial is being conducted at Bonn, Germany.
Who is sponsoring the NCT06352216 clinical trial?
NCT06352216 is sponsored by University Hospital, Bonn. The principal investigator is Andreas C Strauss, PD Dr. med. at University Hospital, Bonn. The trial plans to enroll 300 participants.